Method of Administering Amantadine Prior to a Sleep Period
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application 61/266,053, filed Dec 2, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,741,343 | Method of Administering Amantadine Prior to a Sleep Period In force · High confidence | Adamas Pharma, LLC | In force | High confidence | ||
| US 9,867,791 | Method of administering amantadine prior to a sleep period In force · High confidence | Adamas Pharma, LLC | In force | High confidence | ||
| US 9,867,792 | Method of administering amantadine prior to a sleep period In force · Medium confidence | Adamas Pharma, LLC | In force | Medium confidence | ||
| US 9,867,793 | Method of administering amantadine prior to a sleep period In force · High confidence | Adamas Pharma, LLC | In force | High confidence | ||
| US 9,877,933 | Method of administering amantadine prior to a sleep period In force · High confidence | Adamas Pharma, LLC | In force | High confidence | ||
| US 11,197,835 | Method of administering amantadine prior to a sleep period In force · Medium confidence | Adamas Pharma, LLC | In force | Medium confidence | ||
| Application 14/863,035 | Amantadine Compositions and Methods of Use Abandoned Abandoned Aug 25, 2017 | Adamas Pharma, LLC | Abandoned | Abandoned Aug 25, 2017 | ||
| Application 15/428,920 | Amantadine Compositions and Methods of Use Abandoned Abandoned Nov 30, 2018 | Adamas Pharma, LLC | Abandoned | Abandoned Nov 30, 2018 | ||
| Application 15/428,946 | Amantadine Compositions and Methods of Use Abandoned Abandoned Nov 19, 2018 | Adamas Pharma, LLC | Abandoned | Abandoned Nov 19, 2018 | ||
| Application 15/985,300 | Amantadine Compositions and Methods of Use Abandoned Abandoned Apr 29, 2020 | Adamas Pharma, LLC | Abandoned | Abandoned Apr 29, 2020 |
10 of 10 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Adamas Pharma, LLC.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.